Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-04-03

Clinical Trial Update: Effectivenes of Cyanoacrylate (Glubran 2®) in Reducing Seroma Formation in Breast Cancer Patients Post-Axillary Dissection [NA]

View source ↗

Summary

A clinical trial update evaluating the effectiveness of the cyanoacrylate adhesive Glubran 2 in reducing seroma formation after axillary dissection in breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glubran 2 (cyanoacrylate-based surgical adhesive)

Snippet

Sponsor: King Hussein Cancer Center | Conditions: Breast Cancer | NA | Status: UNKNOWN